Literature DB >> 31907559

Anti-inflammatory activity of the extracts from Rodgersia podophylla leaves through activation of Nrf2/HO-1 pathway, and inhibition of NF-κB and MAPKs pathway in mouse macrophage cells.

Ha Na Kim1, Jeong Dong Kim1, Su Bin Park1, Ho-Jun Son2, Gwang Hun Park2, Hyun Ji Eo2, Hyun-Seok Kim3, Jin Boo Jeong4,5.   

Abstract

OBJECTIVE: Recently, Rodgersia podophylla has been reported to exhibit anti-inflammatory activity. However, little is known about the potential mechanisms about its anti-inflammatory activity. We elucidated the anti-inflammatory mechanisms of leaves extracts from Rodgersia podophylla (RP-L) in RAW264.7 cells.
MATERIALS AND METHODS: LPS-induced NO was measured by Griess and mRNA of pro-inflammatory mediators was analyzed by RT-PCR. Cell viability was measured using MTT assay. The protein level was analyzed by Western blot.
RESULTS: RP-L significantly inhibited the production of the pro-inflammatory mediators such as NO, iNOS, IL-1β and IL-6 in LPS-stimulated RAW264.7 cells. RP-L increased HO-1 expression in RAW264.7 cells, and the inhibition of HO-1 by ZnPP reduced the inhibitory effect of RP-L against LPS-induced NO production in RAW264.7 cells. Inhibition of p38, ROS and GSK3β attenuated RP-L-mediated HO-1 expression. Inhibition of ROS inhibited p38 phosphorylation and GSK3β expression induced by RP-L. In addition, inhibition of GSK3β blocked RP-L-mediated p38 phosphorylation. RP-L induced nuclear accumulation of Nrf2, and inhibition of p38, ROS and GSK3β abolished RP-L-mediated nuclear accumulation of Nrf2. Furthermore, RP-L blocked LPS-induced degradation of IκB-α and nuclear accumulation of p65. RP-L also attenuated LPS-induced phosphorylation of ERK1/2 and p38. In GC/MS analysis of RP-L, pyrogallol was detected as bioactive compound for anti-inflammatory activity of RP-L. Pyrogallol was observed to activate HO-1 expression through ROS/GSK3β/p38/Nrf2/HO-1 signaling.
CONCLUSIONS: Our results suggest that RP-L exerts potential anti-inflammatory activity by activating ROS/GSK3β/p38/Nrf2/HO-1 signaling and inhibiting NF-κB and MAPK signaling in RAW264.7 cells. These findings suggest that RP-L may have great potential for the development of anti-inflammatory drug.

Entities:  

Keywords:  Anti-inflammation; HO-1; MAPKs; Nf-κb; Rodgersia podophylla

Mesh:

Substances:

Year:  2020        PMID: 31907559     DOI: 10.1007/s00011-019-01311-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   6.986


  2 in total

1.  Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition.

Authors:  Stephen J McNally; Ewen M Harrison; James A Ross; O James Garden; Stephen J Wigmore
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

Review 2.  Review of Anti-Inflammatory Herbal Medicines.

Authors:  Mona Ghasemian; Sina Owlia; Mohammad Bagher Owlia
Journal:  Adv Pharmacol Sci       Date:  2016-05-10
  2 in total
  3 in total

1.  Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways.

Authors:  Yihua Piao; Jingzhi Jiang; Zhiguang Wang; Chongyang Wang; Shan Jin; Li Li; Liangchang Li; Hongmei Piao; Zhehu Jin; Lianhua Zhu; Guanghai Yan
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-30       Impact factor: 2.629

2.  Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway.

Authors:  Tony Heurtaux; Melanie Kirchmeyer; Eric Koncina; Paul Felten; Lorraine Richart; Oihane Uriarte Huarte; Herve Schohn; Michel Mittelbronn
Journal:  Cell Mol Neurobiol       Date:  2021-08-20       Impact factor: 4.231

3.  α‑rhamnrtin‑3‑α‑rhamnoside exerts anti‑inflammatory effects on lipopolysaccharide‑stimulated RAW264.7 cells by abrogating NF‑κB and activating the Nrf2 signaling pathway.

Authors:  Jiang Tao Zhou; Kai Da Ren; Jing Hou; Jie Chen; Guan'e Yang
Journal:  Mol Med Rep       Date:  2021-09-15       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.